"World's Most Complete Market Research Reports Repository"

Global Monoclonal Mouse Antibody Market Research Report 2011-2023

Summary
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called ?antigens?). The technology behind the generation of monoclonal antibodies was discovered in 1972 by C?sar Milstein and Georges Kohler ? scientists at the Roche-funded Basel Institute for Immunology ? who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
The global Monoclonal Mouse Antibody market will reach xxx Million USD in 2018 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
IgM
IgG
IgA
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Therapeutic
Research
Diagnostic
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa

Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 IgM
1.2.1.2 IgG
1.2.1.3 IgA
1.2.1.4 Others
1.2.2 by Application
1.2.2.1 Therapeutic
1.2.2.2 Research
1.2.2.3 Diagnostic
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 IgM Market, 2011-2016
4.1.2 IgG Market, 2011-2016
4.1.3 IgA Market, 2011-2016
4.1.4 Others Market, 2011-2016
4.2 Market Forecast
4.2.1 IgM Market Forecast, 2017-2022
4.2.2 IgG Market Forecast, 2017-2022
4.2.3 IgA Market Forecast, 2017-2022
4.2.4 Others Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Therapeutic Market, 2011-2016
5.1.2 Research Market, 2011-2016
5.1.3 Diagnostic Market, 2011-2016
5.2 Market Forecast
5.2.1 Therapeutic Market Forecast, 2017-2022
5.2.2 Research Market Forecast, 2017-2022
5.2.3 Diagnostic Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2011-2016
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2011-2016
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2011-2016
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2011-2016
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2011-2016
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Roche
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Johnson & Johnson
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Merck
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 Novartis
8.4.1 Profile
8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 AbbVie
8.5.1 Profile
8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.6 Amgen
8.6.1 Profile
8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.7 Pfizer
8.7.1 Profile
8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.8 Bayer
8.8.1 Profile
8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.9 Lilly
8.9.1 Profile
8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.10 Bristol-Myers Squibb
8.10.1 Profile
8.10.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.11 GlaxoSmithKline
8.12 Biogen
8.13 AstraZeneca
8.14 Sanofi
8.15 Alexion Pharmaceuticals
8.16 Seattle Genetics
9 Conclusion

Table Product Specifications of Monoclonal Mouse Antibody
Table Products Segment of Monoclonal Mouse Antibody
Table IgM Overview
Table IgG Overview
Table IgA Overview
Table Others Overview
Table Global Monoclonal Mouse Antibody Market by Type, 2011-2022 (USD Million)
Table Application Segment of Monoclonal Mouse Antibody
Table Therapeutic Overview
Table Research Overview
Table Diagnostic Overview
Table Global Monoclonal Mouse Antibody Market by Application, 2011-2022 (USD Million)
Table Global Monoclonal Mouse Antibody Market by Region, 2011-2022 (USD Million)
Table Cost of Monoclonal Mouse Antibody
Table Market Dynamics
Table Policy of Monoclonal Mouse Antibody
Table GDP of Major Countries
Table IgM CAGR by Revenue and Volume, 2011-2016
Table IgG CAGR by Revenue and Volume, 2011-2016
Table IgA CAGR by Revenue and Volume, 2011-2016
Table Others CAGR by Revenue and Volume, 2011-2016
Table IgM CAGR by Revenue and Volume, 2012-2022
Table IgG CAGR by Revenue and Volume, 2012-2022
Table IgA CAGR by Revenue and Volume, 2012-2022
Table Others CAGR by Revenue and Volume, 2012-2022
Table Therapeutic CAGR by Revenue and Volume, 2011-2016
Table Research CAGR by Revenue and Volume, 2011-2016
Table Diagnostic CAGR by Revenue and Volume, 2011-2016

Choose License Type